Lozenges Tantum Verde, eucalyptus flavor, 20 pcs

Pharmacotherapeutic group: non-steroidal anti-inflammatory drug

ATX code: А01AD02

Pharmacological properties

Pharmacodynamics

Benzydamine is a non-steroidal anti-inflammatory drug that belongs to the indazole group.

It has anti-inflammatory and local anesthetic effect, has an antiseptic effect against a wide range of microorganisms.

The mechanism of action of the drug is associated with the stabilization of cell membranes and inhibition of prostaglandin synthesis.

Benzydamine has an antibacterial and specific antimicrobial effect due to the rapid penetration of microorganisms through membranes with subsequent damage to cellular structures, disruption of metabolic processes and cell lysosomes.

Has antifungal action against Candida albicans.

It causes structural modifications of the cell wall of fungi and their metabolic chains, thus interfering with their reproduction, which was the basis for the use of benzydamine in inflammatory processes in the oral cavity, including infectious etiology.

Pharmacokinetics

When applied topically, the drug is well absorbed through the mucous membranes and penetrates into the inflamed tissues, it is found in the blood plasma in an amount insufficient to obtain systemic effects.

Excretion of the drug occurs mainly by the kidneys, in the form of inactive metabolites or conjugation products.

Indications for use

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiology):

- gingivitis, glossitis, stomatitis (including after radiation and chemotherapy)

-pharyngitis, laryngitis, tonsillitis

- candidiasis of the oral mucosa (as part of combination therapy)

-calculous inflammation of the salivary glands

-after surgery and trauma (tonsillectomy, jaw fractures)

-after the treatment and tooth extraction

- periodontal disease

For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum Verde as part of a combination therapy.

Contraindications

- hypersensitivity to benzydamine or other components of the drug

- fructose intolerance

- children under 6 years old

- phenylketonuria

Carefully

Hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including a history).

Application during pregnancy and during breastfeeding

The drug Tantum Verde should not be used during pregnancy and during breastfeeding.

Method of administration and dosage

Locally, after eating.

Adults (including elderly patients) and children over 6 years of age: 1 lozenge 3 times a day.

Keep the tablets in the mouth until they are completely dissolved.

Do not swallow.

Do not chew.

Do not exceed the recommended dose.

For children from 6 to 12 years old, the use of the drug is performed under the supervision of an adult.

The duration of treatment should not exceed 7 days.

If after treatment within 7 days there is no improvement or new symptoms appear, you should consult your doctor.

Use the drug only according to the method of administration and in the doses indicated in the instructions.

If necessary, please consult your doctor before using the medicinal product.

Side effect:

The classification of the incidence of side effects of the World Health Organization (WHO):

very often - 1/10

often - from?

1/100 to < 1/10

infrequently - from? 1/1000 to < 1/100

rarely - from 1/10000 to < 1/1000

very rarely - < 1/10000

frequency unknown - cannot be estimated from the available data.

In each group, adverse effects are presented in order of decreasing severity.

Local reactions: rarely - dry mouth, burning sensation in the mouth

frequency unknown - feeling of numbness in the mouth.

Allergic reactions: infrequently - photosensitivity

rarely - rhea

Dosage

3mg

Structure

Active ingredient: benzydamine hydrochloride 3 mg. Excipients: isomaltose - 3124.43 mg

eucalyptus oil - 3.04 mg

citric acid monohydrate - 1.98 mg

acesulfame potassium - 1.733 mg

levomenthol - 1.733 mg

quinoline yellow dye (E104) - 0.052 mg

dye indigo carmine (E132) - 0.031 mg

Indications

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies): - gingivitis, glossitis, stomatitis (including after radiation and chemotherapy) - pharyngitis, laryngitis, tonsillitis - candidiasis of the oral mucosa (in composition of combination therapy) - calculous inflammation of the salivary glands - after surgical interventions and injuries (tonsillectomy, jaw fractures) - after treatment and tooth extraction - periodontal disease In infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum Verde as part of a combination therapy.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 4 years

INN / Active ingredient

Benzydamine

Contraindications

hypersensitivity to benzydamine or other components of the drug - fructose intolerance - children under 6 years of age - phenylketonuria, With caution, Hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including a history).

Specifications

Category

Sore throat

Scope of the drug

Ear, Throat, Nose

,

Dentistry

Release form

Tablet

Manufacturer country

Switzerland

Package quantity, pcs

twenty

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Minimum humidity,%

25

Maximum humidity,%

60

Brand name

Tantum

The amount of the dosage form in the primary package

1 PC.

Primary packaging type

Paper

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

NSAIDs

Anatomical and therapeutic characteristics

A01AD02 Benzidamine

Dosage form

Lozenges [eucalyptus]

Packaging

Box

Dosage (volume) of the substance in the preparation

benzydamine hydrochloride 3 mg

Expiration date in days

1461

Package weight, g

76

Mode of application

:

Locally, after eating.

Keep the tablets in the mouth until they are completely dissolved, do not swallow, do not chew. < br> The duration of treatment should not exceed 7 days.

If after treatment within 7 days there is no improvement or new symptoms appear, you should consult your doctor. < br> Use the drug only according to the method of application and in those doses indicated in the description.

If necessary, you need to consult a doctor before using the medicinal product.

Information on technical characteristics, delivery set, country of manufacture